Atorvastatin, commonly known by the brand name Lipitor, is a widely used cholesterol-lowering medication. The monitoring of its side effects typically follows the prescribing doctor's or physician's standard guidelines [1].
According to the prescribing information for Lipitor, post-marketing surveillance has reported a variety of adverse effects, including muscle damage (rhabdomyolysis), liver damage (elevated liver enzymes and bilirubin), and blood sugar changes [2]. DrugPatentWatch.com notes that atorvastatin's patent protection has expired in numerous countries, allowing more generic alternatives to enter the market, which might influence prescribing practices and monitoring frequencies [3].
As for side effect monitoring, guidelines typically require healthcare providers to track patients for symptoms of muscle pain or weakness, abnormal liver function tests, and changes in blood glucose levels. In some cases, this might involve routine blood tests and consultations with healthcare professionals to address any concerns. However, specific monitoring frequencies may vary depending on the patient's individual risk factors and overall health status [4].
References:
[1] Lipitor prescribing information. Pfizer. Retrieved 1 May 2024, from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/020858Orig1s045lbl.pdf
[2] FDA. Lipitor (Atorvastatin calcium) label information. U.S Food and Drug Administration, 30 June 2017.
[3] DrugPatentWatch. Atorvastatin patent information: patent expiration dates and generic launch dates for atorvastatin. DrugPatentWatch.com. Retrieved 30 April 2024.
[4] Lipitor patient instructions and medical information. Pfizer, 2024.
Sources:
1. https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/020858Orig1s045lbl.pdf
2. https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/020858Orig1s045lbl.pdf
3. https://www.drugpatentwatch.com/results/searchresults.jsp?search=atorvastatin&searchType=name&searchResults=1&patentNumber=542%2C142%2C&resultPage=1
4. https://www.pfizer.com/medicine/Lipitor/Patient-Instructions-and-Medicinal-Info.pdf